| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.39 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |